Skip To Main Content

Actualización normativa

En un entorno en constante cambio como el sistema de salud, es fundamental mantenerse al día con las nuevas normativas que afectan tanto a profesionales como a pacientes. En este espacio encontrará las leyes, decretos, resoluciones y acuerdos relacionados con el sistema de salud dinámico y en evolución.

También encontrará resúmenes, análisis y todo lo relacionado con la más reciente normatividad, para comprender el posible impacto de los cambios hacia los diferentes actores del sistema.

Ordenar por
Lucienne Chatenoud

Lucienne Chatenoud

Professor of Immunology, Institut Necker Enfants Malades-INEM, Paris, France

Colin Dayan

Colin Dayan

Professor of Clinical Diabetes and Metabolism Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK

Emily K. Sims

Emily K. Sims

Indiana University, Indianapolis, USA

Riitta Veijola

Riitta Veijola

Professor of Pediatrics​, University of Oulu and Oulu University Hospital, Oulu, Finland

The Stages of Type 1 Diabetes

The Stages of Type 1 Diabetes

Explore the stages of type 1 diabetes

Exploring the Etiology of Autoimmune Type 1 Diabetes

Exploring the Etiology of Autoimmune Type 1 Diabetes

Overview of the factors playing a role in the etiology of T1D.

Islet Autoantibodies in T1D

Islet Autoantibodies in T1D

The number, type, and titer of islet autoantibodies detected in T1D screening tests provide valuable information about potential progression to clinical T1D. 

Monitoring Individuals with IAb Positive Status

Monitoring Individuals with IAb Positive Status

Explore how clinical outcomes are impacted by screening and monitoring

From Presymptomatic to Insulin Dependence:  The Stages of Autoimmune Type 1 Diabetes

From Presymptomatic to Insulin Dependence: The Stages of Autoimmune Type 1 Diabetes

An overview of the stages of autoimmune type 1 diabetes, from the development of autoimmunity through to insulin dependence. 

Autoimmunity in Type 1 Diabetes: A Pathophysiology Snapshot

Autoimmunity in Type 1 Diabetes: A Pathophysiology Snapshot

T1D is an autoimmune disease whereby autoreactive T-cells drive progressive beta-cell damage and destruction, ultimately leading to insulin deficiency, dysglycemia, and hyperglycemia. 

 

Metabolic Monitoring in Individuals with Presymptomatic Autoimmune Type 1 Diabetes

Metabolic Monitoring in Individuals with Presymptomatic Autoimmune Type 1 Diabetes

A brief overview of the tools available for monitoring people with presymptomatic autoimmune type 1 diabetes, and the pros and cons for each method.

Monitoring of Presymptomatic Type 1 Diabetes

Monitoring of Presymptomatic Type 1 Diabetes

Monitoring people with early-stage autoimmune T1D may reduce the risk of serious complications, such as DKA.

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

 

MAT-CO-2400825 V1.0 03/2024